Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients-Reference-Cited by-同舟云学术

Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients

Published:2020-10-08 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Russo Vincenzo,Carbone Andreina,Mottola Filiberto Fausto,Mocerino Rosa,Verde Raffaele,Attena Emilio,Verde Nicoletta,Di Micco Pierpaolo,Nunziata Luigi,Santelli Francesco,Nigro Gerardo,Severino Sergio

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference20 articles.

1. Blockade of HERG channels by HIV protease inhibitors;Anson;Lancet,2005

2. Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit;Bessiere;JAMA Cardiol.,2020

3. QT interval prolongation under hydroxychloroquine/ azithromycin association for inpatients with SARS-CoV-2 lower respiratory tract infection;Bun,2020

4. QT Interval Prolongation and Torsade De Pointes in Patients with COVID-19 treated with Hydroxychloroquine/Azithromycin;Chorin;Heart Rhythm.,2020

5. Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin;Cipriani;Int. J. Cardiol.,2020

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential drug-drug interactions in a multi-center study of death cases of COVID-19: The significance of appropriate drug choice;Int. Journal of Clinical Pharmacology and Therapeutics;2023-12-01

2. The potential role of SARS‐CoV‐2 infection in acute coronary syndrome and type 2 myocardial infarction (T2MI): Intertwining spread;Immunity, Inflammation and Disease;2023-03

3. Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study;Frontiers in Pharmacology;2023-01-17

4. QT interval is correlated with and can predict the comorbidity of depression and anxiety: A cross-sectional study on outpatients with first-episode depression;Frontiers in Cardiovascular Medicine;2022-09-29

5. The pharmacology of anticoagulant drug treatment options in COVID-19 patients: reviewing real-world evidence in clinical practice;Expert Review of Clinical Pharmacology;2022-09-02